Maxi Investments CY’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Maxi Investments CY’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,200	Closed	-$1.3M	–	122
2026 Q1	$1.3M	Hold	10,200	–	–	0.28%	55
2025 Q4	$1.24M	Hold	10,200	–	–	0.23%	85
2025 Q3	$1.02M	Buy	10,200 +4,000	+65%	+$360K	0.21%	70
2025 Q2	$514K	Hold	6,200	–	–	0.09%	90
2025 Q1	$503K	Sell	6,200 -7,034	-53%	-$629K	0.1%	107
2024 Q4	$1.19M	Buy	+13,234	New	+$1.28M	0.23%	75

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Maxi Investments CY's XBI Position: Q2 2026 in Review

Maxi Investments CY sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 10,200 shares — an estimated $1.3M sold.

Maxi Investments CY first reported a position in XBI in Q4 2024 and held it in 6 quarters. The position peaked at $1.3M in Q1 2026. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Maxi Investments CY reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
Maxi Investments CY sold 10,200 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.3M.
Maxi Investments CY first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and held it in 6 quarters.
Maxi Investments CY's State Street SPDR S&P Biotech ETF position peaked at $1.3M in Q1 2026.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Maxi Investments CY's 13F filing for Q2 2026, filed 13 Aug 2026.